Multiple myeloma (first line) - bortezomib and thalidomide: patient and professional groups
Multiple myeloma (first line) - bortezomib and thalidomide: Leukaemia CARE response
Multiple myeloma (first line) - bortezomib and thalidomide: Myeloma UK response
Multiple myeloma (first line) - bortezomib and thalidomide: British Society for Haematology & Royal College of Pathologists (joint submission) response
Multiple myeloma (first line) - bortezomib and thalidomide: Royal College of Nursing response
Multiple myeloma (first line) - bortezomib and thalidomide: Royal College of Physicians/NCRI/RCR/ACP/JCCO (joint submission) response
Multiple myeloma (first line) - bortezomib and thalidomide: UK Myeloma Forum response
This page was last updated: 24 August 2010